Atlas Trials

Lapatinib Ditosylate, Trastuzumab, Paclitaxel, and Surgery in Treating Patients With Breast Cancer

Clinical trial NCT01688609 · COMPLETED

Trial details

NCT number
NCT01688609
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
HER2-positive Breast CancerStage II Breast CancerStage IIIA Breast Cancer
Start date
2012-07-01
Primary completion
2013-12-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.